BioMérieux SA Financials

Market Capitalization €13.96 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	32.53
Forward PE	25.91
Price to Sales TTM	€3.51
Price to Book MRQ	€3.32
Enterprise to Revenue	3.49
Enterprise to EBITDA	14.65

Financial Reports as of Jun. 30, 2018

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2018-06-30
Profit Margin	10.86%
Operating Margin	16.82%
Return on Assets TTM	7.23%
Return on Equity TTM	10.68%

Income Statement

Revenue TTM	€3,979,899,904
Revenue per Share TTM	€33.80
Quarterly Revenue Growth	9.10%
Gross Profit TTM	€2,215,300,096
EBITDA	€943,100,000
Net Income to Common TTM	€432,200,000
Diluted EPS TTM	€3.64
Quarterly Earnings Growth YoY	10.70%

Balance Sheet

Total Cash MRQ	€449,800,000
Total Cash per Share MRQ	€3.81
Total Debt MRQ	€
Total Debt to Equity MRQ	11.65
Current Ratio MRQ	2.20
Book Value per Share MRQ	€35.66

Cash Flow

Operating Cash Flow TTM	€667,299,968
Levered Free Cash Flow TTM	€297,787,488

BIM Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	117,929,352
Float Shares	44,593,721
Avg 10 Volume	85,090
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	62.75%
% Held by Institutions	20.85%

Stock Price Summary

Beta	0.48
Fifty Two Week Low	€91.20
Fifty Two Week High	€122.50
Fifty Two Week Change	21.05%
Day 50 MA	€118.49
Day 200 MA	€110.96

Dividends and Splits

Forward Annual Dividend Rate	€3.60
Forward Annual Dividend Yield	3.03%
Trailing Annual Dividend Rate	€0.90
Trailing Annual Dividend Yield	0.76%
Payout Ratio	23.35%
Dividend Date
Ex Dividend Date	2025-06-09
Last Split Factor
Last Split Date	2017-09-20